Insulin therapy
Showing 1 - 25 of >10,000
Liver Dysfunction, Liver Metastasis Colon Cancer, Liver Regeneration Trial (High-Dose Insulin Therapy)
Not yet recruiting
- Liver Dysfunction
- +2 more
- High-Dose Insulin Therapy
- (no location specified)
Nov 6, 2023
Type 2 Diabetic Patients: Real-life Study on Effectiveness and
Not yet recruiting
- Diabete Type 2
- (no location specified)
Nov 2, 2023
Time in Range, Artificial Intelligence, Insulin Therapy Trial in Jingan (Wechat program)
Recruiting
- Time in Range
- +2 more
- Wechat program
-
Shanghai, Shanghai, ChinaXiaolong Zhao
Oct 21, 2022
Type 1 Diabetes Trial in Vancouver (Frexalimab, Placebo, Insulin)
Recruiting
- Type 1 Diabetes Mellitus
- Frexalimab
- +2 more
-
Vancouver, British Columbia, CanadaInvestigational Site Number : 1240001
Oct 31, 2023
Diabetes, Type 1, Diabetes, Type 2 Trial in Erzurum (Health Belief Model-Based Mobile Online Training)
Completed
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Health Belief Model-Based Mobile Online Training
-
Erzurum, TurkeyAtatürk Universty
Mar 24, 2023
Type 2 Diabetes Trial in Changsha (metformin+empagliflozin+insulin glargine, IDegLira, premixed insulin analogues)
Recruiting
- Type 2 Diabetes Mellitus
- metformin+empagliflozin+insulin glargine
- +2 more
-
Changsha, Hunan, ChinaXiangya Hospital of Central South University
Sep 15, 2022
Cystic Fibrosis Trial in Minneapolis, Saint Paul (novolog insulin, levemir insulin, )
Completed
- Cystic Fibrosis
- novolog insulin
- +2 more
-
Minneapolis, Minnesota
- +1 more
Aug 8, 2022
Perioperative Hyperglycaemia, Insulin Therapy, Elective Surgery Trial in Basel, Bern (CamAPS HX, Standard insulin therapy)
Recruiting
- Perioperative Hyperglycaemia
- +9 more
- CamAPS HX
- Standard insulin therapy
-
Basel, Switzerland
- +1 more
Dec 6, 2022
Type 2 Diabetes Trial in Nanjing (Add oral hyppoglycemia drug, Add GLP-1 receptor agonist, Change insulin)
Recruiting
- Type 2 Diabetes Mellitus
- Add oral hyppoglycemia drug
- +2 more
-
Nanjing, ChinaNanjing First Hospital, Nanjing Medical Univesity
Oct 11, 2022
Type 1 Diabetes Trial in Nantes (Bio-mathematical model, Without bio-mathematical model)
Completed
- Type 1 Diabetes
- Bio-mathematical model
- Without bio-mathematical model
-
Nantes, FranceCHU de Nantes
Oct 20, 2022
COVID-19, Dysglycemia Trial in Banha (Insulin, Subcutaneous Insulin)
Completed
- COVID-19
- Dysglycemia
- Insulin
- Subcutaneous Insulin
-
Banhā, El- Qalyobia, EgyptBanha University
Jun 29, 2022
Type 2 Diabetes, Multiple Dose Insulin Therapy Trial (Personalized treatment)
Not yet recruiting
- Type 2 Diabetes Mellitus
- Multiple Dose Insulin Therapy
- Personalized treatment
- (no location specified)
Nov 18, 2023
Type 2 Diabetes Treated With Insulin Trial (t:slim X2 insulin pump with Control-IQ technology 1.5 and Dexcom G6 CGM, Standard
Not yet recruiting
- Type 2 Diabetes Treated With Insulin
- t:slim X2 insulin pump with Control-IQ technology 1.5 and Dexcom G6 CGM
- Standard Therapy plus continuous glucose monitoring (CGM)
- (no location specified)
Mar 14, 2023
Insulia® Tool in Type 2 Diabetes Treated With Basal Insulin
Recruiting
- Type 2 Diabetes Mellitus
-
Corbeil-essonnes Cedex, FranceCentre Hospitalier Sud Francilien
Nov 21, 2022
Diabetes Type 2 - Insulin-Treated Trial in Pittsburgh (Smartphone application and web portal, Standard Insulin Therapy
Active, not recruiting
- Diabetes Mellitus Type 2 - Insulin-Treated
- Smartphone application and web portal
- Standard Insulin Therapy Education
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh Medical Center
Jan 6, 2023
Critical Illness Trial in Leuven (intensive insulin therapy (Actrapid IV to normoglycemia), conventional insulin therapy
Active, not recruiting
- Critical Illness
- intensive insulin therapy (Actrapid IV to normoglycemia)
- conventional insulin therapy (Actrapid IV only for excessive hyperglycemia)
-
Leuven, BelgiumDep Intensive Care Medicine University Hospital Leuven
Mar 8, 2022
GDM, Gestational Diabetes, Nutritional and Metabolic Diseases Trial in Herlev (Dietary treatment)
Not yet recruiting
- GDM
- +4 more
- Dietary treatment
-
Herlev, DenmarkSteno Diabetes Center Copenhagen
Nov 8, 2023
Regimen Switch After Intensive Insulin Therapy
Recruiting
- Insulin
- Continuous intensive insulin therapy
-
Shanghai, Shanghai, China
- +1 more
Oct 27, 2021
Type1diabetes Trial in Naples (Insulin therapy adjustment, Nutritional adjustment, Combination of stategies)
Enrolling by invitation
- Type1diabetes
- Insulin therapy adjustment
- +2 more
-
Naples, ItalyFederico II University Hospital
Jun 30, 2023
Type 1 Diabetes, Prediabetic State, Dysglycemia Trial in Aurora (Early CGM-guided education and initiation of insulin therapy.,
Enrolling by invitation
- Type 1 Diabetes
- +3 more
- Early CGM-guided education and initiation of insulin therapy.
- Usual care: glucometer surveillance and basic education.
-
Aurora, ColoradoBarbara Davis Center
May 6, 2022
Insulin Pump,Continuous Glucose Monitoring Technology Trial in Guandong (Insulin Glargine, Metformin, Dapagliflozin)
Recruiting
- Insulin Pump,Continuous Glucose Monitoring Technology
- Insulin Glargine
- +3 more
-
Guandong, China刘烈华
Nov 7, 2023
Type 2 Diabetes Trial in China (INSULIN GLARGINE (HOE901), Insulin Glulisine, Biphasic insulin aspart 30)
Completed
- Type 2 Diabetes Mellitus
- INSULIN GLARGINE (HOE901)
- +5 more
-
China, ChinaCHINA
Apr 21, 2022
Cystic Fibrosis-related Diabetes Trial in Cambridge, London, Manchester (CamAPS FX, Standard insulin therapy with CGM)
Not yet recruiting
- Cystic Fibrosis-related Diabetes
- CamAPS FX
- Standard insulin therapy with CGM
-
Cambridge, United Kingdom
- +3 more
Jan 3, 2023
Type 1 Diabetes, Basal-bolus Multiple-dily Insulin Injections, Insulin Pump (CSII) Trial in Montpellier (Training course to
Terminated
- Type 1 Diabetes
- +2 more
- Training course to functional insulin therapy
- Usual diabetes management.
-
Montpellier, FranceLapeyronie Hospital - CHU de Montpellier
Dec 9, 2021
Type 2 Diabetes Treated With Insulin Trial in Aalborg (Telemonitoring)
Recruiting
- Type 2 Diabetes Treated With Insulin
- Telemonitoring
-
Aalborg, DenmarkDepartment of Endocrinology
Feb 15, 2022